Episode Details

Back to Episodes
Ep. 129 Weight Watchers' Dr. Michelle Cardel Phd, MS, RD breaks down the *why* of ww's acquisition of Sequence!

Ep. 129 Weight Watchers' Dr. Michelle Cardel Phd, MS, RD breaks down the *why* of ww's acquisition of Sequence!

Episode 129 Published 3 years, 2 months ago
Description

We are talking about it all. Michelle Cardel is explaining Weight Watchers' recent acquisition of Sequence, an online telehealth platform led by medical providers who can in, appropriate cases, prescribe certain weight loss medications.

Michelle I. Cardel, PhD, MS, RD, Head of Clinical Research and Nutrition at WeightWatchers

Dr. Michelle Cardel is an obesity and nutrition scientist and registered dietitian with a research focus on the development and implementation of evidence-based healthy lifestyle strategies.

At WeightWatchers, Michelle oversees the company’s academic research partnerships and clinical trials, nutrition portfolio, and science communication. In collaboration with fellow scientists and teams across the organization, she plans and executes research studies and leads the organization’s nutrition point of view using the latest in nutritional science.

Follow Jenny on instagram @justjennyhutt and twitter + tik tok @jennyhutt  

Please follow this podcast, download, rate and share this and all episodes. Every download is

appreciated.

Email comments and questions to Justjennypod@gmail.com  

TO support Jenny's doing this podcast (and to see video episodes of this podcast) please subscribe

at Patreon.com/jennyhutt

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us